Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122907734 | 12290773 | 4 | F | 20160810 | 20160421 | 20160816 | EXP | US-PFIZER INC-2016226223 | PFIZER | 67.00 | YR | F | Y | 0.00000 | 20160816 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122907734 | 12290773 | 1 | PS | AROMASIN | EXEMESTANE | 1 | Oral | 25 MG, 1X/DAY | 3747190401 | 20753 | 25 | MG | COATED TABLET | QD | |||||
| 122907734 | 12290773 | 2 | SS | AROMASIN | EXEMESTANE | 1 | 25 MG, DAILY | 7088H | 20753 | 25 | MG | COATED TABLET | |||||||
| 122907734 | 12290773 | 3 | C | GEMFIBROZIL. | GEMFIBROZIL | 1 | 800 MG (1 TABLET), 2X/DAY | 0 | 800 | MG | TABLET | BID | |||||||
| 122907734 | 12290773 | 4 | C | GLIPIZIDE. | GLIPIZIDE | 1 | 10 MG (1 TABLET), DAILY | 0 | 10 | MG | TABLET | ||||||||
| 122907734 | 12290773 | 5 | C | LISINOPRIL. | LISINOPRIL | 1 | 10 MG (1 TABLET), DAILY | 0 | 10 | MG | TABLET | ||||||||
| 122907734 | 12290773 | 6 | C | ATENOLOL. | ATENOLOL | 1 | 50 MG (1 TABLET), DAILY | 0 | 50 | MG | TABLET | ||||||||
| 122907734 | 12290773 | 7 | C | CETIRIZINE HCL | CETIRIZINE HYDROCHLORIDE | 1 | 10 MG (1 TABLET), DAILY | 0 | 10 | MG | TABLET | ||||||||
| 122907734 | 12290773 | 8 | C | TRAMADOL HCL | TRAMADOL HYDROCHLORIDE | 1 | 50 MG (1 TABLET), 2X/DAY | 0 | 50 | MG | TABLET | BID | |||||||
| 122907734 | 12290773 | 9 | C | COUMADIN | WARFARIN SODIUM | 1 | Oral | 6 MG (1 TABLET), DAILY | 0 | 6 | MG | TABLET | |||||||
| 122907734 | 12290773 | 10 | C | COUMADIN | WARFARIN SODIUM | 1 | Oral | 3 MG (1 TABLET), DAILY | 0 | 3 | MG | TABLET | |||||||
| 122907734 | 12290773 | 11 | C | FISH OIL | FISH OIL | 1 | 2000 MG, 2X/DAY (2 CAPSULES OF 1000 MG IN THE MORNING AND 2 AT NIGHT) | 0 | 2000 | MG | CAPSULE | BID | |||||||
| 122907734 | 12290773 | 12 | C | COLACE | DOCUSATE SODIUM | 1 | 100 MG (1 TABLET), 2X/DAY | 0 | 100 | MG | CAPSULE | BID | |||||||
| 122907734 | 12290773 | 13 | C | VENTOLIN HFA | ALBUTEROL SULFATE | 1 | 2 DF (2 PUFFS), AS NEEDED (EVERY 4 HOURS) | 0 | 2 | DF | |||||||||
| 122907734 | 12290773 | 14 | C | RANITIDINE HCL | RANITIDINE HYDROCHLORIDE | 1 | Oral | 150 MG (1 TABLET), 2X/DAY | 0 | 150 | MG | CAPSULE | BID | ||||||
| 122907734 | 12290773 | 15 | C | ZOFRAN | ONDANSETRON HYDROCHLORIDE | 1 | 8 MG (1 TABLET), AS NEEDED (EVERY 8 HOURS) | 0 | 8 | MG | TABLET | ||||||||
| 122907734 | 12290773 | 16 | C | ZOFRAN | ONDANSETRON HYDROCHLORIDE | 1 | 0 | TABLET | |||||||||||
| 122907734 | 12290773 | 17 | C | MUPIROCIN. | MUPIROCIN | 1 | UNK, AS NEEDED (2X/DAY) | 0 | OINTMENT | ||||||||||
| 122907734 | 12290773 | 18 | C | BACTRIM DS | SULFAMETHOXAZOLETRIMETHOPRIM | 1 | Oral | 800/160 MG (1 TABLET), 2X/DAY | 0 | TABLET | BID | ||||||||
| 122907734 | 12290773 | 19 | C | MEDROL | METHYLPREDNISOLONE | 1 | 4 MG, UNK | 0 | 4 | MG | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 122907734 | 12290773 | 1 | Breast cancer |
| 122907734 | 12290773 | 2 | Neoplasm malignant |
| 122907734 | 12290773 | 15 | Nausea |
| 122907734 | 12290773 | 16 | Vomiting |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 122907734 | 12290773 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 122907734 | 12290773 | Back pain | |
| 122907734 | 12290773 | Hiatus hernia | |
| 122907734 | 12290773 | Intervertebral disc degeneration | |
| 122907734 | 12290773 | Lipoma | |
| 122907734 | 12290773 | Malaise | |
| 122907734 | 12290773 | Neutropenia | |
| 122907734 | 12290773 | Oedema peripheral | |
| 122907734 | 12290773 | Second primary malignancy | |
| 122907734 | 12290773 | Skin lesion | |
| 122907734 | 12290773 | Thyroid mass | |
| 122907734 | 12290773 | Type 2 diabetes mellitus |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 122907734 | 12290773 | 1 | 20140602 | 0 |